Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Platelet substitute, peptide; GP IIb/IIIa activ...
Macrolide; protein translation inhibitor, mamma...
Polyether cationic ionophore.
Dihydroxyphenolic acid found in cruciferous veg...
Oxyindole alkaloid found in Uncaria sinensis; h...
Oxidized non-cylic hexose sugar.
Endogenous peptide hormone, involved in growth ...
Mast cell stabilizer; TRPV2 antagonist, PDGFR i...
Nitrosourea-amino sugar conjugate, DNA cross-li...
Diterpene found in Anisomeles.
Non-depolarizing NMJ blocker; nAChR antagonist....
JAK2 inhibitor
T-type calcium channel blocker
Flavonoid found in various plant sources; GABA-...
Epoxomicin analog; proteasome inhibitor.
HDAC inhibitor, RNA splicing modulator.
Tyrphostin; IGF-1R inhibitor.
Prevents MHC II antigen presentation.
JAK3 inhibitor.